Elin Borgen Selected Research

Elin Borgen Research Topics

Disease

28	Neoplasms (Cancer) 12/2021 - 10/2004
26	Breast Neoplasms (Breast Cancer) 12/2021 - 10/2004
2	Adenocarcinoma 01/2021 - 09/2015
2	Residual Neoplasm 01/2021 - 11/2020
2	Pathologic Complete Response 01/2021 - 01/2021
2	Carcinoma (Carcinomatosis) 11/2020 - 09/2015
2	Inflammation (Inflammations) 01/2020 - 01/2020
2	Circulating Neoplastic Cells 01/2018 - 01/2014
2	Neoplasm Metastasis (Metastasis) 01/2017 - 12/2016
1	Pancreatic Diseases (Pancreatic Disease) 11/2020
1	Infections 11/2020
1	Hypertension (High Blood Pressure) 11/2020
1	Febrile Neutropenia 11/2020
1	Hemorrhage 11/2020
1	Thrombosis (Thrombus) 01/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019
1	Genomic Instability 11/2018
1	Lymphatic Metastasis 12/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015
1	Genetic Translocation (Chromosomal Translocation) 09/2015
1	Carcinoid Tumor (Carcinoid) 09/2015
1	Large Cell Carcinoma 09/2015
1	Small Cell Carcinoma 09/2015
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 09/2015
1	Premature Aging 01/2015
1	Carcinogenesis 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Leukemia 12/2005

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2014
7	Bevacizumab (Avastin)FDA Link 01/2021 - 08/2017
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2004
5	Phenobarbital (Luminal)FDA Link 12/2021 - 09/2007
4	Estrogen ReceptorsIBA 01/2021 - 08/2017
3	Messenger RNA (mRNA)IBA 01/2020 - 07/2014
2	Hormones (Hormone)IBA 12/2021 - 02/2011
2	human ERBB2 proteinIBA 01/2021 - 11/2020
2	Tamoxifen FDA LinkGeneric 01/2021 - 11/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2012
2	Keratins (Keratin)IBA 11/2020 - 02/2011
2	Biological ProductsIBA 01/2020 - 09/2010
2	Pharmaceutical PreparationsIBA 10/2019 - 01/2019
2	Epirubicin (Ellence)FDA LinkGeneric 11/2018 - 12/2014
2	Fluorouracil (Carac)FDA LinkGeneric 11/2018 - 12/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2018 - 12/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 12/2016
2	Docetaxel (Taxotere)FDA Link 12/2014 - 07/2014
2	AntibodiesIBA 02/2011 - 10/2004
1	Formaldehyde (Formol)FDA Link 12/2021
1	ParaffinIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	pertuzumabIBA 11/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2021
1	Trastuzumab (Herceptin)FDA Link 11/2021
1	4-hydroxy-N-desmethyltamoxifenIBA 01/2021
1	Factor VIII (Coagulation Factor VIII)IBA 01/2021
1	CytokinesIBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	Factor V (Coagulation Factor V)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Growth Differentiation Factor 15IBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2019
1	ProteomeIBA 01/2019
1	taxaneIBA 11/2018
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 11/2017
1	EnzymesIBA 11/2017
1	Nut ProteinsIBA 09/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 09/2015
1	Mammaglobin AIBA 07/2014
1	Keratin-19 (Keratin 19)IBA 07/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2012
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2012
1	Indicators and Reagents (Reagents)IBA 05/2011
1	Apoptosis Inducing FactorIBA 12/2005
1	5-aminolevulinic acid hexyl ester FDA Link 12/2005
1	protoporphyrin IXIBA 12/2005
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2005
1	AcidsIBA 12/2005
1	ErbB-2 ReceptorIBA 10/2004

Therapy/Procedure

11	Therapeutics 12/2021 - 04/2008
8	Neoadjuvant Therapy 01/2021 - 08/2012
6	Drug Therapy (Chemotherapy) 12/2021 - 12/2014
1	Hepatectomy 11/2015
1	Castration 01/2014
1	Photochemotherapy (Photodynamic Therapy) 12/2005